Participants: sites
Site selection
Expressions of interest to participate in the POPPI cluster RCT were received from 118 NHS adult, general critical care units across England, Wales and Northern Ireland. Potential sites were asked to complete a site feasibility questionnaire, of which 86 completed questionnaires and were subsequently assessed for eligibility by the ICNARC CTU.
Relative to the target of 24 participating sites – of 86 potential sites completing a questionnaire – 32 sites did not meet inclusion criteria (e.g. had insufficient resources/capacity to deliver the trial or would see too few patients over the trial period). The final 24 sites were selected from the remaining 54 sites, with reasons for selection including good research track-record and display of a high level of enthusiasm. A small number of sites were already delivering early psychological support and so were not selected. In addition to the 24 sites, we selected eight reserve sites to be approached in the event that a selected site was no longer able to participate.
One site that was initially selected lost eligibility to take part as a result of inability to implement use of the CAM-ICU68 to assess delirium prior to the start of the trial (see Chapter 4 for the inclusion criteria for sites). A site from the reserve list was rapidly set up as a replacement.
Site set-up
A total of 24 sites (22 in England, one in Wales and one in Northern Ireland) obtained local NHS permissions/approvals and opened to recruitment in three groups of eight sites, at 2-month intervals. Sites allocated to the first group opened to recruitment on 1 September 2015. Groups two and three opened on 2 November 2015 and 4 January 2016, respectively. One site in group three opened 3 days late, owing to delays in obtaining local NHS permissions through the Christmas/New Year period. Site initiation visits were carried out at all participating sites prior to start of patient screening and recruitment. Sites were randomised in their second month of recruitment (during the baseline period). The flow of sites (clusters) through the cluster RCT is presented in Figure 12, according to the CONSORT extension for cluster trials.80
FIGURE 12 The CONSORT flow of sites (clusters) and patients. ICU, intensive care unit. Reproduced with permission from JAMA 2019;321(7):665–75.71 Copyright © 2019 American Medical Association. All rights reserved. (Figure not reproduced here; see the original article.)
Overall, as planned, 24 sites participated in the POPPI cluster RCT. One site from the second group of sites closed in December 2016 prior to the end of the recruitment period because key staff were scheduled onto other projects when the recruitment period was extended. The remaining 23 sites remained open to screening and recruitment until the end of recruitment in January 2017.
Intervention site set-up
Following site randomisation, each intervention group site identified three self-selected POPPI nurses (plus one reserve), according to the person specification. Each POPPI nurse signed a form confirming their commitment to undertake the POPPI nurse role. Intervention site initiation visits were carried at all intervention group sites ahead of the 3-day training course and prior to commencement of the transition period.
In total, 38 POPPI nurses were trained across the series of three central 3-day training courses held in February, April and June 2016. For two sites, the reserve POPPI nurses was also trained – one because an original POPPI nurse went on a career break and the other to help provide increased cover for delivery of the stress support sessions at one of the larger participating intervention group sites.
Characteristics of participating sites
The characteristics of the 24 adult, general critical care units that participated in the POPPI cluster RCT compared with all other adult, general critical care units in the CMP (n = 191) are presented in Table 6. Overall, a representative mix of university and non-university/university-affiliated hospitals, geographically spread across England, Wales and Northern Ireland, took part in the cluster RCT. A higher proportion of larger units participated in the POPPI cluster RCT compared with all other units participating in the CMP. Use of diaries in the critical care units was reported at the start of the study at nine intervention and seven control sites.
| Critical care unit characteristic | Units in the POPPI cluster RCT (N = 24), n (%) | Units in the CMPa (N = 191), n (%) |
|---|---|---|
| Region | ||
| North | 8 (33.3) | 55 (28.8) |
| Midlands/East | 3 (12.5) | 35 (18.3) |
| London/South East | 2 (8.3) | 50 (26.2) |
| South West/South Central | 9 (37.5) | 29 (15.2) |
| Wales | 1 (4.2) | 14 (7.3) |
| Northern Ireland | 1 (4.2) | 8 (4.2) |
| Type of hospital | ||
| University | 8 (33.3) | 56 (29.3) |
| Non-university/university affiliated | 16 (66.7) | 135 (70.7) |
| Size of critical care unit (beds) | ||
| < 8 | 2 (8.3) | 33 (17.3) |
| 8–11 | 5 (20.8) | 68 (35.6) |
| 12–15 | 7 (29.2) | 36 (18.8) |
| ≥ 16 | 10 (41.7) | 54 (28.3) |
| Annual critical care unit admissions | ||
| < 500 | 2 (8.3) | 47 (24.6) |
| 500–749 | 5 (20.8) | 62 (32.5) |
| 750–999 | 8 (33.3) | 41 (21.5) |
| ≥ 1000 | 9 (37.5) | 41 (21.5) |
Participants: patients
Screening
Table 7 summarises data from screening and enrolment logs maintained by participating sites, stratified by treatment group (usual care or intervention) and time period (baseline, transition and intervention).
| Screening and recruitment | Baseline period | Transition period | Intervention period | |||
|---|---|---|---|---|---|---|
| Usual care | Intervention | Usual care | Intervention | Usual care | Intervention | |
| Not eligible, n/N (% of screened) | 4543/5051 (89.9) | 3724/4257 (87.5) | 830/927 (89.3) | 728/827 (88.0) | 7240/8106 (89.3) | 6432/7290 (88.2) |
| Did not meet stable criteria (n)a | 3644 | 3131 | 658 | 599 | 5828 | 5393 |
| < 48 hours in critical care unit, n (%) | 2129 (58.4) | 1898 (60.6) | 405 (61.6) | 391 (65.3) | 3351 (57.5) | 3461 (64.2) |
| No level 3 care in first 48 hours in unit, n (%) | 1407 (38.6) | 1089 (34.8) | 216 (32.8) | 176 (29.4) | 2253 (38.7) | 1652 (30.6) |
| Aged < 18 years, n (%) | 26 (0.7) | 19 (0.6) | 8 (1.2) | 0 (0) | 59 (1.0) | 30 (0.6) |
| Not English-speaking, n (%) | 45 (1.2) | 27 (0.9) | 6 (0.9) | 4 (0.7) | 80 (1.4) | 27 (0.5) |
| Previously recruited to the POPPI intervention, n (%) | 16 (0.4) | 16 (0.5) | 8 (1.2) | 2 (0.3) | 33 (0.6) | 24 (0.4) |
| Chronic cognitive impairment,b n (%) | 92 (2.5) | 49 (1.6) | 18 (2.7) | 14 (2.3) | 113 (1.9) | 97 (1.8) |
| Psychotic illness,b n (%) | 77 (2.1) | 76 (2.4) | 15 (2.3) | 15 (2.5) | 134 (2.3) | 134 (2.5) |
| Chronic PTSD,b n (%) | 9 (0.2) | 2 (0.1) | 1 (0.2) | 1 (0.2) | 23 (0.4) | 23 (0.4) |
| Did not meet transient criteria (n)a | 899 | 593 | 172 | 129 | 1412 | 1039 |
| Not able to communicate orally, n (%) | 384 (42.7) | 118 (19.9) | 54 (31.4) | 22 (17.1) | 426 (30.2) | 214 (20.6) |
| RASS score not between + 1 and –1, n (%) | 172 (19.1) | 76 (12.8) | 30 (17.4) | 11 (8.5) | 239 (16.9) | 158 (15.2) |
| GCS score of < 15, n (%) | 543 (60.4) | 304 (51.3) | 105 (61.0) | 59 (45.7) | 814 (57.6) | 563 (54.2) |
| Receiving end-of-life care, n (%) | 289 (32.1) | 248 (41.8) | 59 (34.3) | 48 (37.2) | 404 (28.6) | 394 (37.9) |
| Not able to consent, n (%) | 199 (22.1) | 81 (13.7) | 34 (19.8) | 21 (16.3) | 323 (22.9) | 191 (18.4) |
| Potentially eligible (n) | 508 | 533 | 97 | 99 | 866 | 858 |
| Missed (e.g. out-of-hours, no staff), n (%) | 96 (18.9) | 144 (27.0) | 17 (17.5) | 27 (27.3) | 194 (22.4) | 247 (28.8) |
| Other reasons not approached, n (%) | 32 (6.3) | 28 (5.3) | 4 (4.1) | 3 (3.0) | 46 (5.3) | 75 (8.7) |
| Approached for informed consent, n (%) | 380 (74.8) | 361 (67.7) | 76 (78.4) | 69 (69.7) | 626 (72.3) | 536 (62.5) |
| Eligible and approached for consent (n) | 380 | 361 | 76 | 69 | 626 | 536 |
| Declined consent, n (%) | 95 (25.0) | 76 (21.1) | 18 (23.7) | 27 (39.1) | 180 (28.8) | 194 (36.2) |
| Provided informed consent, n (%) | 285 (75.0) | 285 (78.9) | 58 (76.3) | 42 (60.8) | 446 (71.2) | 342 (63.8) |
| Withdrew consent, n (%) | 1 (0.4) | 2 (0.7) | 0 (0) | 0 (0) | 0 (0) | 2 (0.6) |
| Included in primary analysis (n) | 284 | 283 | 0 | 0 | 446 | 340 |
Of the patients who were deemed to be potentially eligible for the trial, the numbers of patients who were reported as being missed appeared to increase over time, in both usual care and intervention sites. The most commonly reported reason was that there was a relatively short time frame from a patient regaining capacity and being discharged from the critical care unit (the initial approach for consent was to be made in the unit). In addition, patients were often also missed because of a lack of resources to enable screening and recruitment in the evenings and at weekends. A similar trend was observed with regards to refusals of consent, with increasing refusals over time in both treatment groups, but higher rates of refusals being observed in patients at intervention group sites during the intervention period. The reported reasons for declining consent varied (but were consistent across treatment groups and time periods); often, patients felt too tired/fatigued to take part, others felt that they were not ‘up to’ completing questionnaires and that taking part in a research study would be burdensome to them. Some patients were already taking part in other studies and therefore did not want to consider a further study (even when co-enrolment was permitted between the studies).
Recruitment
A total of 1458 participants were recruited between 1 September 2015 and 3 February 2017. Figure 13 shows the cumulative patient recruitment against the anticipated pre-trial sample size and the revised minimum target. There was variation across the 24 participating sites in the rate of recruitment; the overall mean monthly recruitment rate was 4.1 (range 1.8–6.6) patients per site per month.
FIGURE 13 Patient recruitment. (Figure not reproduced here; see the original article.)
Patients were generally recruited into the POPPI cluster RCT during weekdays (Monday to Friday). Less than 10% of patients were recruited on either a Saturday or a Sunday (Figure 14). Most participating sites reported having insufficient resources to enable screening and recruitment outside usual office hours. Five participants (0.3%) withdrew consent, resulting in 1453 participants being included in the final sample. The 100 participants recruited during the transition (training) period were excluded from the primary analyses, as planned.
FIGURE 14 Percentage of patients recruited by day of the week. (Figure not reproduced here; see the original article.)
Patient characteristics
The groups were well matched across treatment groups and time periods (Tables 8–10). The mean age of patients was similar (baseline period: 57.2 years in the usual care group and 59.5 years in the intervention group; intervention period: 57.2 years in the usual care group and 60.4 years in the intervention group). The sample was predominantly white in ethnicity and ≈60% of recruited participants were male (this proportion was slightly lower at intervention group sites during the intervention period: 55% male).
| Characteristic | Baseline period | Intervention period | ||
|---|---|---|---|---|
| Usual care (N = 284) | Intervention (N = 283) | Usual care (N = 446) | Intervention (N = 340) | |
| Age (years) | ||||
| Mean (SD) | 57.2 (16.2) | 59.5 (16.0) | 57.2 (15.6) | 60.4 (15.0) |
| Median (IQR) | 60 (46–69) | 62 (48–72) | 58 (47–68) | 62 (51–70) |
| Sex, n (%) | ||||
| Female | 105 (37.0) | 115 (40.6) | 178 (39.9) | 153 (45.0) |
| Male | 179 (63.0) | 168 (59.4) | 268 (60.1) | 187 (55.0) |
| Ethnicity, n (%) | ||||
| White | 264 (93.0) | 254 (89.8) | 406 (91.0) | 320 (94.1) |
| Mixed | 1 (0.4) | 0 (0.0) | 2 (0.4) | 1 (0.3) |
| Asian | 3 (1.1) | 4 (1.4) | 6 (1.3) | 1 (0.3) |
| Black | 1 (0.4) | 7 (2.5) | 2 (0.4) | 3 (0.9) |
| Other | 0 (0.0) | 8 (2.8) | 4 (0.9) | 2 (0.6) |
| Not stated | 15 (5.3) | 10 (3.5) | 26 (5.8) | 13 (3.8) |
| Quintile of IMD 2015, n (%) | ||||
| 1 (least deprived) | 57 (20.1) | 41 (14.5) | 95/445 (21.3) | 57/338 (16.9) |
| 2 | 65 (22.9) | 46 (16.3) | 107/445 (24.0) | 74/338 (21.9) |
| 3 | 52 (18.3) | 56 (19.8) | 73/445 (16.4) | 76/338 (22.5) |
| 4 | 57 (20.1) | 71 (25.1) | 88/445 (19.8) | 73/338 (21.6) |
| 5 (most deprived) | 53 (18.7) | 69 (24.4) | 82/445 (18.4) | 58/338 (17.2) |
| Documented pre-existing anxiety/depression, n (%) | ||||
| Anxiety | 4 (1.4) | 3 (1.1) | 9 (2.0) | 12 (3.5) |
| Depression | 19 (6.7) | 19 (6.7) | 33 (7.4) | 32 (9.4) |
| Both | 8 (2.8) | 17 (6.0) | 13 (2.9) | 21 (6.2) |
| None | 253 (89.1) | 244 (86.2) | 391 (87.7) | 275 (80.9) |
| Characteristic | Baseline period | Intervention period | ||
|---|---|---|---|---|
| Usual care (N = 284) | Intervention (N = 283) | Usual care (N = 446) | Intervention (N = 340) | |
| Elective surgical admission, n (%) | ||||
| Yes | 24 (8.5) | 17 (6.0) | 37 (8.3) | 20 (5.9) |
| No | 260 (91.5) | 266 (94.0) | 409 (91.7) | 320 (94.1) |
| ICNARC Physiology Scorea | ||||
| Mean (SD) | 21.2 (7.1) | 21.1 (7.0) | 21.4 (7.2) | 21.0 (7.6) |
| Median (IQR) | 21 (16–25) | 21 (16–26) | 21 (17–26) | 20 (16–25) |
| APACHE II scorea | ||||
| Mean (SD) | 16.7 (5.8) | 16.9 (6.5) | 16.9 (6.2) | 17.7 (6.4) |
| Median (IQR) | 16 (13–20) | 16 (12–21) | 16 (13–21) | 17 (13–22) |
| Characteristic | Baseline period | Intervention period | ||
|---|---|---|---|---|
| Usual care (N = 284) | Intervention (N = 283) | Usual care (N = 446) | Intervention (N = 340) | |
| Duration of critical care unit stay prior to consent (days) | ||||
| Mean (SD) | 9.1 (7.4) | 9.8 (8.8) | 11.0 (11.6) | 12.1 (13.2) |
| Median (IQR) | 6 (4–11) | 7 (4–12) | 7 (4–13) | 7 (4–14) |
| CAM-ICU positive (delirium) days in critical care prior to consent | n = 113 | n = 162 | n = 180 | n = 147 |
| Mean (SD) | 2.3 (3.2) | 1.4 (2.2) | 2.8 (3.5) | 1.7 (3.0) |
| Median (IQR) | 1 (0–3) | 1 (0–2) | 2 (1–3) | 1 (0–2) |
| Days from critical care unit admission to consent | ||||
| Mean (SD) | 9.6 (7.5) | 10.5 (9.1) | 11.9 (11.7) | 13.2 (13.4) |
| Median (IQR) | 7 (4–12) | 7 (4–13) | 8 (5–14) | 9 (5–15) |
| Proportion of patients consented in critical care unit, n (%) | 236 (83.1) | 225 (79.5) | 337 (75.6) | 224 (65.9) |
| Last NEWS prior to consenta | ||||
| Mean (SD) | 3.1 (2.4) | 3.2 (2.2) | 2.8 (2.4) | 2.8 (2.1) |
| Median (IQR) | 3 (1–5) | 3 (2–5) | 2 (1–4) | 3 (1–4) |
| STAI-6 at time of consent | n = 284 | n = 282 | n = 445 | n = 340 |
| Mean (SD) | 43.6 (15.5) | 45.0 (16.0) | 42.1 (14.2) | 43.8 (17.1) |
| Median (IQR) | 43 (30–53) | 43 (33–57) | 43 (33–50) | 43 (30–55) |
| HRQoL (health thermometer score) at time of consent | n = 284 | n = 283 | n = 445 | n = 340 |
| Mean (SD) | 52.9 (23.3) | 52.4 (25.7) | 54.9 (23.3) | 51.0 (25.6) |
| Median (IQR) | 50 (40–70) | 50 (35–70) | 50 (40–70) | 50 (30–70) |
The majority of participants were medical admissions to the critical care unit, with a slightly higher proportion of planned surgical admissions at usual care group sites (than in intervention group sites). Patients’ severity of illness, assessed using the APACHE II scoring system and based on physiology variables during the first 24 hours of unit admission, was similar across treatment groups and time periods (median score of 16, and slightly higher at intervention group sites during the intervention period, with a median score of 17).
During the baseline period, patients were consented, on average, 9.6 (usual care group) and 10.5 (intervention group) days after admission to the critical care unit; compared with 11.9 and 13.2 days, respectively, during the intervention period. The proportion of patients consented in the unit, as opposed to on the wards after critical care discharge, was lower at intervention group sites during the intervention period than during all other trial time periods. At the time of consent, median STAI-6 and quality-of-life health thermometer scores were the same across treatment groups and time periods.
To assess case-mix representativeness, patients in the cluster RCT were compared with a best approximation of the POPPI eligibility criteria applied to the CMP database for both POPPI cluster RCT units and all other adult, general, critical care units participating in the CMP (non-POPPI units; Table 11). Patients who were recruited to the cluster RCT were representative of similar patients in the CMP, but were more likely to be white and not from the most deprived areas (according to quintile of IMD 2015).76
| Characteristic | POPPI cluster RCT patients (N = 1453) | POPPI eligibility applied to the CMP dataa | |
|---|---|---|---|
| POPPI sites (N = 8189) | Non-POPPI sites (N = 50,208) | ||
| Age (years) | |||
| Mean (SD) | 58.0 (15.8) | 58.7 (17.1) | 59.3 (17.0) |
| Median (IQR) | 60 (48–70) | 61 (47–72) | 62 (48–73) |
| Sex (%) | |||
| Female | 41.2 | 39.6 | 41.0 |
| Male | 58.8 | 60.4 | 59.0 |
| Ethnicity (%) | |||
| White | 96.4 | 93.0 | 89.4 |
| Mixed | 0.3 | 0.3 | 0.7 |
| Asian | 1.2 | 3.0 | 4.8 |
| Black | 1.1 | 1.9 | 3.3 |
| Other | 1.0 | 1.8 | 1.9 |
| Quintile of IMD 2015 (%) | |||
| 1 (least deprived) | 18.0 | 16.2 | 14.6 |
| 2 | 21.0 | 17.8 | 17.4 |
| 3 | 19.2 | 19.9 | 19.4 |
| 4 | 21.8 | 21.5 | 22.6 |
| 5 (most deprived) | 20.0 | 24.6 | 26.0 |
| Elective surgical admission (%) | |||
| Yes | 7.1 | 7.8 | 6.7 |
| No | 92.9 | 92.2 | 93.3 |
| ICNARC Physiology Scoreb | |||
| Mean (SD) | 21.2 (7.3) | 20.8 (7.3) | 20.4 (7.2) |
| Median (IQR) | 21 (16–26) | 20 (16–25) | 20 (15–25) |
| APACHE II scoreb | |||
| Mean (SD) | 17.1 (6.3) | 17.4 (6.6) | 16.7 (6.4) |
| Median (IQR) | 17 (13–21) | 17 (13–22) | 16 (12–21) |
| Critical care unit length of stay (days) | |||
| Mean (SD) | 11.3 (13.5) | 9.3 (12.5) | 9.9 (12.0) |
| Median (IQR) | 6 (3–13) | 5 (3–10) | 5 (3–11) |
Patient follow-up
At 6 months, all participants were successfully followed up for mortality status. Of those surviving to 6 months, 79.3% completed the follow-up questionnaire (range 78.4–79.9% across treatment groups and time periods; Table 12). There were no differences in response rates between groups or time periods. The majority of questionnaires were completed on paper and returned via post.
| Follow-up | Baseline period | Intervention period | ||
|---|---|---|---|---|
| Usual care (N = 284) | Intervention (N = 283) | Usual care (N = 446) | Intervention (N = 340) | |
| Outcome at 6 months, n (%) | ||||
| Alive | 259 (91.2) | 245 (86.6) | 415 (93.0) | 314 (92.4) |
| Dead | 25 (8.8) | 38 (13.4) | 31 (7.0) | 26 (7.6) |
| Lost to follow-up | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Returned questionnaire, n/N (% of those alive at 6 months) | ||||
| Completed | 203/259 (78.4) | 193/245 (78.8) | 331/415 (79.8) | 251/314 (79.9) |
| Refused | 22/259 (8.5) | 25/245 (10.2) | 31/415 (7.5) | 19/314 (6.1) |
| Lost to follow-up | 34/259 (13.1) | 27/245 (11.0) | 53/415 (12.8) | 44/314 (14.0) |
| Method of completion, n/N (% of completed questionnaires) | ||||
| Paper | 178/203 (87.7) | 173/193 (89.6) | 315/331 (95.2) | 240/251 (95.6) |
| Telephone | 25/203 (12.3) | 20/193 (10.4) | 16/331 (4.8) | 11/251 (4.4) |
| Method of refusal, n/N (% of those who refused) | ||||
| Paper | 13/22 (59.1) | 8/25 (32.0) | 15/31 (48.4) | 10/19 (52.6) |
| Telephone | 10/22 (45.5) | 17/25 (68.0) | 16/31 (51.6) | 9/19 (47.4) |
| Complete responses by instrument, n/N (% of completed questionnaires) | ||||
| PSS-SR | 201/203 (99.0) | 191/193 (99.0) | 330/331 (99.7) | 250/251 (99.6) |
| HADS anxiety | 196/203 (96.6) | 186/193 (96.4) | 327/331 (98.8) | 246/251 (98.0) |
| HADS depression | 196/203 (96.6) | 186/193 (96.4) | 327/331 (98.8) | 247/251 (98.4) |
| EQ-5D-5L | 197/203 (97.0) | 188/193 (97.4) | 320/331 (96.7) | 248/251 (98.8) |
| Health services | 135/203 (66.5) | 122/193 (63.2) | 226/331 (68.3) | 161/251 (64.1) |
Of returned completed questionnaires, data completeness for the primary outcome measure (PSS-SR score) was high (> 99%). Data completeness for the HADS67 and EQ-5D-5L56 were also high (> 96%), but less complete responses were received for the health services questionnaire (note that this questionnaire appeared last in the questionnaire booklet).
For participants alive at 6 months, response rates varied by patient characteristics (Table 13). Response rates were lowest in the youngest age group, and were generally lower for females than for males, for non-white ethnicities than for those of white ethnicity, and for patients with higher levels of deprivation. However, there appeared to be no clear relationship between response rate and either baseline acute severity of illness or anxiety and HRQoL at the time of consent. For patients receiving the intervention, the response rate increased with the number of stress support sessions received.
| Characteristic | Baseline period | Intervention period | ||
|---|---|---|---|---|
| Usual care (N = 259), n/N (%) | Intervention (N = 245), n/N (%) | Usual care (N = 415), n/N (%) | Intervention (N = 314), n/N (%) | |
| Age (years) | ||||
| 18–49 | 53/81 (65.4) | 50/68 (73.5) | 89/123 (72.4) | 47/68 (69.1) |
| 50–59 | 42/51 (82.4) | 41/50 (82.0) | 84/103 (81.6) | 61/73 (83.6) |
| 60–69 | 63/69 (91.3) | 57/67 (85.1) | 83/102 (81.4) | 77/91 (84.6) |
| ≥ 70 | 45/58 (77.6) | 45/60 (75.0) | 75/87 (86.2) | 66/82 (80.5) |
| Sex | ||||
| Female | 67/94 (71.3) | 77/104 (74.0) | 129/164 (78.7) | 113/145 (77.9) |
| Male | 136/165 (82.4) | 116/141 (82.3) | 202/251 (80.5) | 138/169 (81.7) |
| Ethnicity | ||||
| White | 190/240 (79.2) | 177/223 (79.4) | 298/377 (79.0) | 239/294 (81.3) |
| Non-white | 3/5 (60.0) | 9/14 (64.3) | 9/13 (69.2) | 2/7 (28.6) |
| Not stated | 10/14 (71.4) | 7/8 (87.5) | 24/25 (96.0) | 10/13 (76.9) |
| Quintile of IMD 2015 | ||||
| 1 (least deprived) | 50/54 (92.6) | 27/31 (87.1) | 79/89 (88.8) | 46/55 (83.6) |
| 2 | 45/55 (81.8) | 28/40 (70.0) | 84/97 (86.6) | 55/67 (82.1) |
| 3 | 32/48 (66.7) | 43/51 (84.3) | 52/70 (74.3) | 56/66 (84.8) |
| 4 | 40/51 (78.4) | 47/64 (73.4) | 63/83 (75.9) | 56/71 (78.9) |
| 5 (most deprived) | 36/51 (70.6) | 48/59 (81.4) | 52/75 (69.3) | 36/53 (67.9) |
| Pre-existing anxiety/depression | ||||
| Anxiety | 3/4 (75.0) | 0/1 (0.0) | 6/9 (66.7) | 9/11 (81.8) |
| Depression | 13/19 (68.4) | 13/18 (72.2) | 25/32 (78.1) | 24/31 (77.4) |
| Both | 4/8 (50.0) | 13/17 (76.5) | 9/11 (81.8) | 13/21 (61.9) |
| None | 183/228 (80.3) | 167/209 (79.9) | 291/363 (80.2) | 205/251 (81.7) |
| Elective surgical admission | ||||
| Yes | 16/19 (84.2) | 9/11 (81.8) | 29/36 (80.6) | 18/19 (94.7) |
| No | 187/240 (77.9) | 184/234 (78.6) | 302/379 (79.7) | 233/295 (79.0) |
| ICNARC Physiology Score | ||||
| < 17 | 59/73 (80.8) | 55/75 (73.3) | 83/105 (79.0) | 73/95 (76.8) |
| 17–21 | 56/75 (74.7) | 48/64 (75.0) | 89/118 (75.4) | 82/91 (90.1) |
| 22–26 | 44/55 (80.0) | 50/61 (82.0) | 82/103 (79.6) | 48/64 (75.0) |
| ≥ 27 | 44/56 (78.6) | 40/45 (88.9) | 77/89 (86.5) | 48/64 (75.0) |
| APACHE II score | ||||
| < 14 | 65/80 (81.3) | 58/79 (73.4) | 90/124 (72.6) | 65/89 (73.0) |
| 14–17 | 58/79 (73.4) | 58/71 (81.7) | 100/117 (85.5) | 72/89 (80.9) |
| 18–21 | 42/50 (84.0) | 37/45 (82.2) | 74/90 (82.2) | 52/61 (85.2) |
| ≥ 22 | 38/50 (76.0) | 40/50 (80.0) | 65/82 (79.3) | 62/75 (82.7) |
| CAM-ICU positive (delirious) in unit prior to consent (days) | ||||
| 0 | 19/33 (57.6) | 50/67 (74.6) | 20/29 (69.0) | 46/61 (75.4) |
| 1–2 | 33/41 (80.5) | 43/55 (78.2) | 65/84 (77.4) | 35/42 (83.3) |
| > 2 | 21/30 (70.0) | 17/22 (77.3) | 42/55 (76.4) | 30/35 (85.7) |
| Last NEWS prior to consent | ||||
| 0–1 | 56/77 (72.7) | 48/56 (85.7) | 124/157 (79.0) | 76/92 (82.6) |
| 2–3 | 67/81 (82.7) | 70/97 (72.2) | 109/130 (83.8) | 88/116 (75.9) |
| 4 | 26/35 (74.3) | 19/28 (67.9) | 25/37 (67.6) | 35/41 (85.4) |
| ≥ 5 | 54/66 (81.8) | 56/64 (87.5) | 73/91 (80.2) | 52/65 (80.0) |
| STAI-6 score at time of consent | ||||
| 20–30 | 54/71 (76.1) | 44/53 (83.0) | 81/103 (78.6) | 74/98 (75.5) |
| 31–43 | 58/70 (82.9) | 59/78 (75.6) | 111/145 (76.6) | 67/73 (91.8) |
| 44–53 | 44/58 (75.9) | 43/52 (82.7) | 78/96 (81.3) | 50/64 (78.1) |
| 54–80 | 47/60 (78.3) | 47/61 (77.0) | 60/70 (85.7) | 60/79 (75.9) |
| HRQoL health thermometer score at time of consent | ||||
| 0–38 | 49/62 (79.0) | 48/63 (76.2) | 71/86 (82.6) | 77/92 (83.7) |
| 39–50 | 66/82 (80.5) | 54/66 (81.8) | 97/125 (77.6) | 61/82 (74.4) |
| 51–70 | 41/53 (77.4) | 46/58 (79.3) | 80/102 (78.4) | 58/72 (80.6) |
| 71–100 | 47/62 (75.8) | 45/58 (77.6) | 83/101 (82.2) | 55/68 (80.9) |
| IPAT score of < 7 | – | – | – | 103/128 (80.5) |
| IPAT score of ≥ 7 by number of stress support sessions received | ||||
| None | – | – | – | 9/16 (56.3) |
| 1 | – | – | – | 13/19 (68.4) |
| 2 | – | – | – | 24/31 (77.4) |
| 3 | – | – | – | 102/120 (85.0) |
Multiple imputation
Table 14 reports all of the variables considered for multiple imputation, and for each variable, the number of missing values, and the imputation model chosen.
| Variable | Missing values, n (%) | Imputation model |
|---|---|---|
| Site-level covariates | ||
| Teaching status of hospital | 0 (0) | None required |
| Number of beds in the critical care unit | 0 (0) | None required |
| Number of critical care unit admissions receiving level 3 care staying ≥ 48 hours | 0 (0) | None required |
| Allocated treatment group | 0 (0) | None required |
| Patient-level covariates | ||
| Time period | 0 (0) | None required |
| Age | 0 (0) | None required |
| Sex | 0 (0) | None required |
| Ethnicity | 0 (0) | None required (‘not stated’ retained as separate category) |
| IMD 2015 quintile | 3 (< 0.1) | Singly imputed to category 3 (middle quintile) |
| Pre-existing anxiety/depression | 0 (0) | None required |
| Elective surgical admission | 0 (0) | None required |
| ICNARC physiology score | 0 (0) | None required |
| NEWS | 0 (0) | None required |
| HRQoL health thermometer score | 1 (< 0.1) | Singly imputed to mean |
| STAI-6 score | 2 (< 0.1) | Missing items singly imputed to mode |
| Duration of stay in the critical care unit (days) | 0 (0) | None required |
| Number of days of delirium | 0 (0) | None required (not assessed retained as separate category) |
| Number of days receiving sedatives/anxiolytics/anaesthetics | 0 (0) | None required |
| Number of days receiving sleep medications | 0 (0) | None required |
| Receipt of benzodiazepines | 0 (0) | None required |
| Number of days receiving antipsychotics | 0 (0) | None required |
| Number of days receiving vasoactive agents | 0 (0) | None required |
| Number of days receiving analgesics | 0 (0) | None required |
| Number of days receiving antidepressants | 0 (0) | None required |
| Number of days receiving mechanical ventilation | 0 (0) | None required |
| Duration of stay in hospital following discharge from the critical care unit (days) | 0 (0) | None required |
| Adherence to intervention | 0 (0) | None required |
| Length of stay in general medical wards (days) | 0 (0) | None required |
| Outcomes and resource use at 6 months | ||
| Costs of ICU stay (£) | 0 (0) | None required |
| Mortality | 0 (0) | None required |
| PSS-SR score | 283 (21.4) | Predictive mean matching |
| HADS anxiety score | 303 (22.9) | Predictive mean matching |
| HADS depression score | 302 (22.8) | Predictive mean matching |
| EQ-5D-5L health utility | 302 (22.8) | Predictive mean matching |
| Health services questionnaire costs (£) | 631 (47.7) | Predictive mean matching |